Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-022-00555-0, published online 3 June 2022
In this article, author names Yu-Hsuan Joni Shao, Jian-Hua Hong, Chun-Kai Chen, and Chao-Yuan Huang were incorrectly written as Shao Yu-Hsuan Joni, Hong Jian-Hua, Chen Chun-Kai, and Huang Chao-Yuan.
Tables 1 and 2 have been adjusted to reflect consistency within the paper. They now show as seen below.
In the sentence beginning with “Risk groups defined by National Comprehensive Cancer Network...” value “20 ng/ml” has been changed to “>20 ng/mL”.
In this article and insertion to the caption to Fig 1 has been made. In the sentence beginning with “Survival curves...” it now reads as “Survival curves showing MACE-free survival probability (significance of difference tested by log rank test)...”.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shao, YH.J., Hong, JH., Chen, CK. et al. Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan. Prostate Cancer Prostatic Dis 26, 631–632 (2023). https://doi.org/10.1038/s41391-022-00568-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41391-022-00568-9
